Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Polycystic Kidney, Autosomal Dominant | 31 | 2022 | 166 | 4.760 |
Why?
|
Kidney Failure, Chronic | 44 | 2020 | 2471 | 1.980 |
Why?
|
Renal Dialysis | 30 | 2020 | 1801 | 1.330 |
Why?
|
Kidney | 24 | 2022 | 7064 | 1.000 |
Why?
|
Polycystic Kidney Diseases | 3 | 2015 | 133 | 0.930 |
Why?
|
Kidney Diseases | 7 | 2016 | 2093 | 0.700 |
Why?
|
Glomerular Filtration Rate | 24 | 2022 | 2180 | 0.700 |
Why?
|
Nephrology | 5 | 2010 | 263 | 0.650 |
Why?
|
Angiotensin-Converting Enzyme Inhibitors | 11 | 2018 | 1523 | 0.610 |
Why?
|
TRPP Cation Channels | 6 | 2020 | 177 | 0.590 |
Why?
|
Diet, Sodium-Restricted | 2 | 2016 | 291 | 0.530 |
Why?
|
Hyperoxaluria | 1 | 2014 | 32 | 0.480 |
Why?
|
Calcium Oxalate | 1 | 2014 | 75 | 0.460 |
Why?
|
Managed Care Programs | 4 | 2002 | 939 | 0.450 |
Why?
|
Carnitine | 2 | 2005 | 252 | 0.420 |
Why?
|
Hypertension | 12 | 2018 | 8594 | 0.390 |
Why?
|
Antihypertensive Agents | 7 | 2018 | 2061 | 0.380 |
Why?
|
Kidney Calculi | 2 | 2014 | 468 | 0.380 |
Why?
|
Disease Progression | 21 | 2022 | 13502 | 0.370 |
Why?
|
Health Planning Guidelines | 1 | 2010 | 151 | 0.330 |
Why?
|
Cathartics | 1 | 2008 | 127 | 0.290 |
Why?
|
Metoprolol | 1 | 2007 | 92 | 0.290 |
Why?
|
Renal Replacement Therapy | 1 | 2009 | 281 | 0.290 |
Why?
|
Ramipril | 1 | 2007 | 97 | 0.290 |
Why?
|
Models, Organizational | 1 | 2010 | 545 | 0.270 |
Why?
|
Hematuria | 3 | 2002 | 233 | 0.260 |
Why?
|
Acute Kidney Injury | 8 | 2020 | 1941 | 0.260 |
Why?
|
AIDS-Associated Nephropathy | 1 | 2005 | 34 | 0.240 |
Why?
|
Creatinine | 5 | 2008 | 1903 | 0.240 |
Why?
|
Lisinopril | 2 | 2014 | 55 | 0.240 |
Why?
|
Phosphates | 1 | 2008 | 772 | 0.240 |
Why?
|
Nephritis, Interstitial | 2 | 2002 | 154 | 0.230 |
Why?
|
Renal Insufficiency, Chronic | 5 | 2020 | 2290 | 0.230 |
Why?
|
Induced Pluripotent Stem Cells | 1 | 2015 | 1846 | 0.220 |
Why?
|
Angiotensin II Type 1 Receptor Blockers | 4 | 2014 | 435 | 0.220 |
Why?
|
Renin-Angiotensin System | 3 | 2018 | 738 | 0.220 |
Why?
|
Quality Indicators, Health Care | 2 | 2012 | 1824 | 0.220 |
Why?
|
Benzoates | 2 | 2014 | 212 | 0.210 |
Why?
|
Pain | 5 | 2013 | 5066 | 0.210 |
Why?
|
Vitamin B Complex | 1 | 2005 | 297 | 0.210 |
Why?
|
Health Maintenance Organizations | 3 | 2002 | 660 | 0.200 |
Why?
|
Hemodialysis Units, Hospital | 2 | 2002 | 22 | 0.200 |
Why?
|
Catholicism | 1 | 2002 | 33 | 0.200 |
Why?
|
Hypercalcemia | 1 | 2005 | 421 | 0.200 |
Why?
|
Adrenergic beta-Antagonists | 1 | 2007 | 1259 | 0.200 |
Why?
|
Capitation Fee | 2 | 1999 | 116 | 0.180 |
Why?
|
Humans | 116 | 2022 | 760621 | 0.180 |
Why?
|
Colonoscopy | 1 | 2008 | 1387 | 0.180 |
Why?
|
Angiotensin Receptor Antagonists | 3 | 2018 | 1031 | 0.170 |
Why?
|
Quality of Health Care | 8 | 2010 | 4360 | 0.170 |
Why?
|
Benzimidazoles | 2 | 2014 | 858 | 0.160 |
Why?
|
Organ Size | 5 | 2020 | 2254 | 0.160 |
Why?
|
Kidney Diseases, Cystic | 1 | 2000 | 183 | 0.160 |
Why?
|
Peritoneal Dialysis, Continuous Ambulatory | 2 | 1996 | 27 | 0.160 |
Why?
|
Mutation | 7 | 2021 | 29932 | 0.150 |
Why?
|
Serum Albumin | 2 | 2000 | 674 | 0.150 |
Why?
|
Randomized Controlled Trials as Topic | 8 | 2018 | 10344 | 0.150 |
Why?
|
Practice Management, Medical | 1 | 1999 | 191 | 0.140 |
Why?
|
Bone Diseases | 1 | 2020 | 419 | 0.140 |
Why?
|
Diatrizoate | 1 | 1996 | 81 | 0.140 |
Why?
|
Diatrizoate Meglumine | 1 | 1996 | 79 | 0.140 |
Why?
|
Antiretroviral Therapy, Highly Active | 1 | 2005 | 1894 | 0.130 |
Why?
|
Clarithromycin | 1 | 1996 | 85 | 0.130 |
Why?
|
Keto Acids | 3 | 1998 | 34 | 0.130 |
Why?
|
Germ Layers | 1 | 2015 | 71 | 0.130 |
Why?
|
Congresses as Topic | 2 | 2009 | 805 | 0.120 |
Why?
|
Hepatomegaly | 1 | 2014 | 84 | 0.120 |
Why?
|
Heart | 1 | 2007 | 4393 | 0.120 |
Why?
|
Sodium Chloride, Dietary | 1 | 2016 | 293 | 0.120 |
Why?
|
Disease Management | 2 | 2002 | 2514 | 0.120 |
Why?
|
Technology | 1 | 2016 | 291 | 0.120 |
Why?
|
Medicare | 5 | 2011 | 6786 | 0.110 |
Why?
|
Kidney Transplantation | 8 | 2002 | 4215 | 0.110 |
Why?
|
Medical History Taking | 1 | 2017 | 773 | 0.110 |
Why?
|
Nutritional Status | 2 | 2000 | 1607 | 0.110 |
Why?
|
Blood Pressure | 9 | 2018 | 8525 | 0.110 |
Why?
|
Tissue and Organ Procurement | 1 | 2002 | 944 | 0.110 |
Why?
|
Middle Aged | 52 | 2021 | 220352 | 0.110 |
Why?
|
Hallucinations | 1 | 1996 | 366 | 0.110 |
Why?
|
Crohn Disease | 1 | 2005 | 2275 | 0.100 |
Why?
|
Dietary Supplements | 1 | 2005 | 3392 | 0.100 |
Why?
|
Insurance Coverage | 1 | 2003 | 1939 | 0.100 |
Why?
|
Male | 57 | 2022 | 359744 | 0.100 |
Why?
|
Fibroblast Growth Factors | 1 | 2017 | 869 | 0.100 |
Why?
|
Patient Care Team | 3 | 2012 | 2511 | 0.090 |
Why?
|
Octreotide | 1 | 2012 | 153 | 0.090 |
Why?
|
National Health Insurance, United States | 1 | 1991 | 100 | 0.090 |
Why?
|
Dietary Proteins | 8 | 1998 | 949 | 0.090 |
Why?
|
Adult | 48 | 2021 | 219994 | 0.090 |
Why?
|
Curcumin | 1 | 2012 | 99 | 0.090 |
Why?
|
Organ Transplantation | 1 | 2001 | 1150 | 0.090 |
Why?
|
Vitamin D | 1 | 2005 | 3291 | 0.090 |
Why?
|
Cyclic AMP | 1 | 2015 | 1456 | 0.090 |
Why?
|
Alleles | 1 | 2021 | 6898 | 0.090 |
Why?
|
United States | 19 | 2012 | 72461 | 0.090 |
Why?
|
Indazoles | 1 | 2012 | 302 | 0.090 |
Why?
|
Abdominal Pain | 2 | 2008 | 1063 | 0.090 |
Why?
|
Referral and Consultation | 2 | 2001 | 3598 | 0.090 |
Why?
|
Benzazepines | 1 | 2012 | 311 | 0.090 |
Why?
|
Arteriovenous Shunt, Surgical | 2 | 2011 | 294 | 0.090 |
Why?
|
Medicaid | 1 | 2003 | 2815 | 0.080 |
Why?
|
Organoids | 1 | 2015 | 729 | 0.080 |
Why?
|
Hypertrophy, Left Ventricular | 2 | 2011 | 854 | 0.080 |
Why?
|
Female | 53 | 2022 | 391270 | 0.080 |
Why?
|
Kidney Function Tests | 3 | 2021 | 681 | 0.080 |
Why?
|
Analgesics | 2 | 2009 | 1065 | 0.080 |
Why?
|
Pluripotent Stem Cells | 1 | 2015 | 792 | 0.080 |
Why?
|
Health Care Rationing | 1 | 1992 | 435 | 0.080 |
Why?
|
Carrier Proteins | 1 | 2021 | 4938 | 0.080 |
Why?
|
Embryonic Stem Cells | 1 | 2015 | 1262 | 0.080 |
Why?
|
Uremia | 5 | 1989 | 201 | 0.070 |
Why?
|
Pancreas Transplantation | 2 | 2001 | 196 | 0.070 |
Why?
|
Insurance, Health, Reimbursement | 1 | 2011 | 385 | 0.070 |
Why?
|
Treatment Outcome | 13 | 2018 | 65017 | 0.070 |
Why?
|
Amino Acids, Essential | 1 | 1987 | 26 | 0.070 |
Why?
|
Brain Diseases | 1 | 1996 | 1540 | 0.070 |
Why?
|
Gastrointestinal Agents | 1 | 2012 | 509 | 0.070 |
Why?
|
Reimbursement Mechanisms | 1 | 1992 | 664 | 0.070 |
Why?
|
Urine | 1 | 2008 | 363 | 0.070 |
Why?
|
Diet, Protein-Restricted | 2 | 1998 | 73 | 0.070 |
Why?
|
Age Factors | 5 | 2018 | 18416 | 0.070 |
Why?
|
Sodium | 1 | 2012 | 1594 | 0.070 |
Why?
|
TOR Serine-Threonine Kinases | 1 | 2015 | 2058 | 0.060 |
Why?
|
Lipofuscin | 3 | 1991 | 40 | 0.060 |
Why?
|
Nausea | 1 | 2008 | 678 | 0.060 |
Why?
|
Pain Measurement | 4 | 2013 | 3528 | 0.060 |
Why?
|
Young Adult | 12 | 2020 | 58741 | 0.060 |
Why?
|
Kidney Neoplasms | 1 | 2002 | 4312 | 0.060 |
Why?
|
Anemia, Hypochromic | 1 | 2005 | 63 | 0.060 |
Why?
|
History, 20th Century | 2 | 2010 | 2773 | 0.060 |
Why?
|
Glomerular Mesangium | 1 | 2005 | 98 | 0.060 |
Why?
|
Iritis | 1 | 1984 | 15 | 0.060 |
Why?
|
Health Care Costs | 1 | 1998 | 3258 | 0.060 |
Why?
|
Catheterization, Central Venous | 1 | 2009 | 526 | 0.060 |
Why?
|
Sirolimus | 1 | 2012 | 1547 | 0.060 |
Why?
|
Phenotype | 3 | 2021 | 16546 | 0.060 |
Why?
|
Double-Blind Method | 6 | 2014 | 12427 | 0.060 |
Why?
|
Metformin | 1 | 2012 | 912 | 0.060 |
Why?
|
Risk Assessment | 8 | 2020 | 24123 | 0.060 |
Why?
|
Delivery of Health Care | 2 | 1992 | 5325 | 0.050 |
Why?
|
Image Processing, Computer-Assisted | 1 | 2020 | 8950 | 0.050 |
Why?
|
Prevalence | 3 | 2013 | 15687 | 0.050 |
Why?
|
Seizures | 1 | 1996 | 2917 | 0.050 |
Why?
|
Contrast Media | 1 | 1996 | 5305 | 0.050 |
Why?
|
Specialties, Nursing | 1 | 2002 | 10 | 0.050 |
Why?
|
Captopril | 1 | 1983 | 265 | 0.050 |
Why?
|
Intracellular Signaling Peptides and Proteins | 1 | 2013 | 2873 | 0.050 |
Why?
|
Government Agencies | 1 | 2003 | 160 | 0.050 |
Why?
|
Aged | 26 | 2021 | 169152 | 0.050 |
Why?
|
Drug Therapy, Combination | 4 | 2014 | 6498 | 0.050 |
Why?
|
Cysts | 2 | 2022 | 683 | 0.050 |
Why?
|
Prednisone | 4 | 1995 | 1565 | 0.050 |
Why?
|
Flank Pain | 1 | 2002 | 43 | 0.050 |
Why?
|
Health Services Needs and Demand | 1 | 2010 | 1399 | 0.050 |
Why?
|
Health Policy | 2 | 2012 | 2677 | 0.050 |
Why?
|
Magnetic Resonance Imaging | 7 | 2022 | 36290 | 0.050 |
Why?
|
Time Factors | 11 | 2018 | 40165 | 0.050 |
Why?
|
Hydroxymethylglutaryl-CoA Reductase Inhibitors | 1 | 2017 | 3334 | 0.050 |
Why?
|
Genetic Predisposition to Disease | 2 | 2021 | 17790 | 0.050 |
Why?
|
Quality of Life | 3 | 2013 | 13308 | 0.050 |
Why?
|
Proline | 1 | 1983 | 457 | 0.050 |
Why?
|
Adolescent | 12 | 2018 | 87810 | 0.050 |
Why?
|
Microscopy, Electron | 1 | 2005 | 2558 | 0.050 |
Why?
|
Immunoglobulin A | 1 | 2005 | 979 | 0.050 |
Why?
|
Proteomics | 1 | 2015 | 3817 | 0.050 |
Why?
|
Signal Transduction | 2 | 2015 | 23376 | 0.050 |
Why?
|
Health Status | 1 | 2013 | 4081 | 0.040 |
Why?
|
Prospective Studies | 9 | 2022 | 54303 | 0.040 |
Why?
|
Genotype | 3 | 2020 | 12960 | 0.040 |
Why?
|
Diagnosis, Differential | 2 | 2008 | 12965 | 0.040 |
Why?
|
Drug Eruptions | 1 | 1983 | 335 | 0.040 |
Why?
|
Liver Diseases | 3 | 2022 | 1302 | 0.040 |
Why?
|
Multivariate Analysis | 4 | 2018 | 12159 | 0.040 |
Why?
|
Protein-Energy Malnutrition | 1 | 2000 | 188 | 0.040 |
Why?
|
Genetic Association Studies | 2 | 2021 | 2717 | 0.040 |
Why?
|
Transcutaneous Electric Nerve Stimulation | 1 | 2001 | 170 | 0.040 |
Why?
|
Withholding Treatment | 1 | 2004 | 613 | 0.040 |
Why?
|
Heart Ventricles | 1 | 2011 | 3811 | 0.040 |
Why?
|
Hypoglycemic Agents | 1 | 2012 | 3150 | 0.040 |
Why?
|
Immunosuppressive Agents | 1 | 2012 | 4166 | 0.040 |
Why?
|
Minerals | 1 | 2020 | 283 | 0.040 |
Why?
|
Genomics | 1 | 2015 | 5794 | 0.040 |
Why?
|
Hypotension | 1 | 2005 | 883 | 0.040 |
Why?
|
Pigments, Biological | 2 | 1988 | 52 | 0.040 |
Why?
|
Social Adjustment | 1 | 2001 | 632 | 0.040 |
Why?
|
Eosinophilia | 1 | 1983 | 559 | 0.040 |
Why?
|
Age of Onset | 1 | 2005 | 3301 | 0.040 |
Why?
|
Niacinamide | 1 | 2020 | 414 | 0.040 |
Why?
|
Multicenter Studies as Topic | 2 | 2017 | 1722 | 0.040 |
Why?
|
Chi-Square Distribution | 2 | 2017 | 3465 | 0.040 |
Why?
|
Brain Death | 1 | 2002 | 356 | 0.040 |
Why?
|
Catheters, Indwelling | 2 | 2011 | 428 | 0.040 |
Why?
|
High-Throughput Nucleotide Sequencing | 2 | 2021 | 3616 | 0.040 |
Why?
|
Independent Practice Associations | 1 | 1997 | 21 | 0.040 |
Why?
|
Decision Making | 1 | 1992 | 3925 | 0.040 |
Why?
|
Hospital-Physician Joint Ventures | 1 | 1997 | 30 | 0.040 |
Why?
|
Cation Exchange Resins | 1 | 1997 | 19 | 0.040 |
Why?
|
Back Pain | 1 | 2001 | 543 | 0.040 |
Why?
|
Cadaver | 1 | 2002 | 1345 | 0.040 |
Why?
|
Cecal Diseases | 1 | 1997 | 49 | 0.040 |
Why?
|
Cilia | 1 | 2021 | 493 | 0.040 |
Why?
|
Chest Pain | 1 | 2004 | 1106 | 0.040 |
Why?
|
Polystyrenes | 1 | 1997 | 104 | 0.040 |
Why?
|
Stomach Ulcer | 1 | 1997 | 123 | 0.040 |
Why?
|
Antidepressive Agents | 1 | 2009 | 2890 | 0.040 |
Why?
|
Anti-Bacterial Agents | 1 | 1996 | 7408 | 0.040 |
Why?
|
Amino Acid Substitution | 1 | 2021 | 1737 | 0.040 |
Why?
|
Ileal Diseases | 1 | 1997 | 69 | 0.040 |
Why?
|
Acupuncture Therapy | 1 | 2001 | 480 | 0.040 |
Why?
|
Death | 1 | 2002 | 678 | 0.040 |
Why?
|
Amino Acids | 2 | 1998 | 1714 | 0.040 |
Why?
|
Natriuresis | 1 | 2016 | 105 | 0.040 |
Why?
|
Proportional Hazards Models | 3 | 2018 | 12531 | 0.030 |
Why?
|
Aldosterone | 2 | 2014 | 868 | 0.030 |
Why?
|
Quality Improvement | 1 | 2012 | 3836 | 0.030 |
Why?
|
Drug Administration Schedule | 1 | 2005 | 4899 | 0.030 |
Why?
|
Physician Assistants | 1 | 1999 | 188 | 0.030 |
Why?
|
Living Donors | 1 | 2001 | 636 | 0.030 |
Why?
|
Tomography, X-Ray Computed | 4 | 2020 | 20509 | 0.030 |
Why?
|
Protein Kinase Inhibitors | 1 | 2013 | 5643 | 0.030 |
Why?
|
Headache | 1 | 2004 | 1249 | 0.030 |
Why?
|
Mosaicism | 1 | 2019 | 466 | 0.030 |
Why?
|
Biological Specimen Banks | 1 | 2021 | 783 | 0.030 |
Why?
|
Practice Guidelines as Topic | 2 | 2012 | 7475 | 0.030 |
Why?
|
Low Back Pain | 1 | 2004 | 979 | 0.030 |
Why?
|
Anemia | 2 | 1996 | 1511 | 0.030 |
Why?
|
Risk Factors | 7 | 2020 | 74359 | 0.030 |
Why?
|
Catatonia | 1 | 1978 | 178 | 0.030 |
Why?
|
Obesity | 1 | 2017 | 12922 | 0.030 |
Why?
|
Ultrasonography | 1 | 2008 | 5961 | 0.030 |
Why?
|
Patient Advocacy | 1 | 1997 | 358 | 0.030 |
Why?
|
Urinary Tract Infections | 1 | 2001 | 814 | 0.030 |
Why?
|
Hypertension, Renal | 1 | 1995 | 141 | 0.030 |
Why?
|
Sialoglycoproteins | 1 | 2015 | 315 | 0.030 |
Why?
|
Azathioprine | 4 | 1995 | 356 | 0.030 |
Why?
|
Nephrectomy | 1 | 2000 | 1016 | 0.030 |
Why?
|
Phosphorus, Dietary | 1 | 1993 | 20 | 0.030 |
Why?
|
Renal Artery Obstruction | 2 | 1991 | 224 | 0.030 |
Why?
|
Cyclophosphamide | 1 | 1980 | 2221 | 0.030 |
Why?
|
Antilymphocyte Serum | 1 | 1995 | 482 | 0.030 |
Why?
|
Sex Factors | 2 | 2018 | 10547 | 0.030 |
Why?
|
Pedigree | 1 | 2021 | 4578 | 0.030 |
Why?
|
Predictive Value of Tests | 3 | 2020 | 15289 | 0.030 |
Why?
|
Body Height | 1 | 2020 | 1570 | 0.030 |
Why?
|
Hospitalization | 3 | 2012 | 10790 | 0.030 |
Why?
|
Linear Models | 2 | 2017 | 5877 | 0.030 |
Why?
|
Prognosis | 4 | 2018 | 29658 | 0.030 |
Why?
|
Severity of Illness Index | 2 | 2018 | 15840 | 0.030 |
Why?
|
Nitrogen | 4 | 1990 | 350 | 0.030 |
Why?
|
Biopsy, Needle | 1 | 2018 | 1630 | 0.030 |
Why?
|
DNA Copy Number Variations | 1 | 2021 | 2013 | 0.030 |
Why?
|
Liver | 2 | 2022 | 7509 | 0.030 |
Why?
|
Liver Function Tests | 1 | 2014 | 524 | 0.030 |
Why?
|
Tissue Donors | 2 | 2002 | 2313 | 0.030 |
Why?
|
Graft Survival | 2 | 1995 | 3794 | 0.030 |
Why?
|
Gene Knockout Techniques | 1 | 2015 | 802 | 0.030 |
Why?
|
Confidence Intervals | 1 | 2018 | 2932 | 0.030 |
Why?
|
ROC Curve | 1 | 2020 | 3568 | 0.030 |
Why?
|
Pruritus | 3 | 1982 | 377 | 0.020 |
Why?
|
Regression Analysis | 2 | 2011 | 6360 | 0.020 |
Why?
|
Odds Ratio | 2 | 2017 | 9716 | 0.020 |
Why?
|
Lung Transplantation | 1 | 2001 | 1305 | 0.020 |
Why?
|
Cost-Benefit Analysis | 2 | 2011 | 5508 | 0.020 |
Why?
|
Longitudinal Studies | 2 | 2018 | 14495 | 0.020 |
Why?
|
Energy Intake | 2 | 1996 | 2129 | 0.020 |
Why?
|
Albuminuria | 1 | 2014 | 659 | 0.020 |
Why?
|
Sequence Analysis, DNA | 1 | 2021 | 4713 | 0.020 |
Why?
|
Biopsy | 2 | 2002 | 6771 | 0.020 |
Why?
|
Adaptation, Psychological | 1 | 2001 | 2628 | 0.020 |
Why?
|
Drug Combinations | 1 | 1996 | 2025 | 0.020 |
Why?
|
Erythropoietin | 1 | 1994 | 720 | 0.020 |
Why?
|
Pain Clinics | 1 | 2009 | 51 | 0.020 |
Why?
|
Abortion, Legal | 1 | 1971 | 114 | 0.020 |
Why?
|
Water-Electrolyte Balance | 1 | 2010 | 325 | 0.020 |
Why?
|
Bayes Theorem | 1 | 2018 | 2326 | 0.020 |
Why?
|
Extracellular Fluid | 1 | 2010 | 165 | 0.020 |
Why?
|
Logistic Models | 2 | 2017 | 13314 | 0.020 |
Why?
|
Liver Transplantation | 1 | 2001 | 2325 | 0.020 |
Why?
|
Radioisotopes | 1 | 1990 | 495 | 0.020 |
Why?
|
Antineoplastic Agents | 1 | 2012 | 13630 | 0.020 |
Why?
|
Patient-Centered Care | 1 | 1999 | 1416 | 0.020 |
Why?
|
Genetic Testing | 1 | 2021 | 3531 | 0.020 |
Why?
|
Follow-Up Studies | 5 | 2017 | 39261 | 0.020 |
Why?
|
3-Hydroxyanthranilic Acid | 1 | 1987 | 8 | 0.020 |
Why?
|
Up-Regulation | 1 | 2017 | 4122 | 0.020 |
Why?
|
Ultraviolet Therapy | 2 | 1979 | 84 | 0.020 |
Why?
|
Laparoscopy | 1 | 2000 | 2147 | 0.020 |
Why?
|
Membrane Lipids | 1 | 1989 | 251 | 0.020 |
Why?
|
Catheters | 1 | 2011 | 425 | 0.020 |
Why?
|
Arteriosclerosis | 2 | 1991 | 1064 | 0.020 |
Why?
|
Government Regulation | 1 | 2012 | 525 | 0.020 |
Why?
|
Erythrocyte Membrane | 1 | 1989 | 439 | 0.020 |
Why?
|
Heart Transplantation | 1 | 2001 | 3224 | 0.020 |
Why?
|
Antidepressive Agents, Tricyclic | 1 | 2009 | 432 | 0.020 |
Why?
|
Comorbidity | 1 | 2002 | 10551 | 0.020 |
Why?
|
Patient Care Planning | 1 | 1973 | 908 | 0.020 |
Why?
|
Fatty Acids, Nonesterified | 1 | 1989 | 393 | 0.020 |
Why?
|
Patient Acceptance of Health Care | 1 | 2001 | 3164 | 0.020 |
Why?
|
Quality Assurance, Health Care | 1 | 1997 | 2176 | 0.020 |
Why?
|
Respiratory Insufficiency | 1 | 1976 | 1231 | 0.020 |
Why?
|
Sodium Channels | 1 | 1989 | 344 | 0.020 |
Why?
|
Saponins | 1 | 1986 | 50 | 0.020 |
Why?
|
Hepatitis B Surface Antigens | 1 | 1988 | 301 | 0.020 |
Why?
|
Forecasting | 1 | 2016 | 2932 | 0.020 |
Why?
|
Cohort Studies | 2 | 2020 | 41335 | 0.020 |
Why?
|
Overweight | 1 | 2017 | 2421 | 0.020 |
Why?
|
Body Mass Index | 2 | 2017 | 12914 | 0.020 |
Why?
|
Potassium Channels | 1 | 1989 | 534 | 0.020 |
Why?
|
Adrenal Insufficiency | 1 | 1968 | 192 | 0.020 |
Why?
|
Program Development | 1 | 2012 | 1297 | 0.020 |
Why?
|
Digoxin | 1 | 1986 | 247 | 0.020 |
Why?
|
Pain Threshold | 1 | 2009 | 603 | 0.020 |
Why?
|
Boston | 1 | 2018 | 9280 | 0.020 |
Why?
|
Abortion, Induced | 1 | 1971 | 460 | 0.020 |
Why?
|
Postoperative Care | 1 | 1992 | 1479 | 0.020 |
Why?
|
Chronic Disease | 2 | 2011 | 9287 | 0.020 |
Why?
|
Canada | 1 | 2010 | 2128 | 0.020 |
Why?
|
Image Interpretation, Computer-Assisted | 1 | 2017 | 3340 | 0.010 |
Why?
|
Mass Screening | 1 | 2000 | 5423 | 0.010 |
Why?
|
History, 21st Century | 1 | 2010 | 1575 | 0.010 |
Why?
|
Immunohistochemistry | 1 | 2018 | 11071 | 0.010 |
Why?
|
Coronary Angiography | 1 | 1996 | 4563 | 0.010 |
Why?
|
Sodium-Potassium-Exchanging ATPase | 1 | 1986 | 477 | 0.010 |
Why?
|
Cardiovascular Diseases | 1 | 2009 | 15757 | 0.010 |
Why?
|
Dose-Response Relationship, Drug | 2 | 2009 | 10827 | 0.010 |
Why?
|
Fibrosis | 1 | 2010 | 2042 | 0.010 |
Why?
|
Health Services Accessibility | 1 | 2001 | 5397 | 0.010 |
Why?
|
Socioeconomic Factors | 1 | 1997 | 7806 | 0.010 |
Why?
|
Registries | 2 | 2010 | 8469 | 0.010 |
Why?
|
Aged, 80 and over | 5 | 2010 | 58995 | 0.010 |
Why?
|
Iothalamic Acid | 2 | 1994 | 17 | 0.010 |
Why?
|
Cross-Sectional Studies | 2 | 2014 | 25942 | 0.010 |
Why?
|
Bacterial Infections | 1 | 2011 | 1403 | 0.010 |
Why?
|
Diabetes Mellitus | 1 | 2001 | 5889 | 0.010 |
Why?
|
Medical Futility | 1 | 2004 | 133 | 0.010 |
Why?
|
Hepatitis B | 1 | 1988 | 701 | 0.010 |
Why?
|
Retrospective Studies | 4 | 2020 | 80372 | 0.010 |
Why?
|
Computers | 2 | 1976 | 595 | 0.010 |
Why?
|
Combined Modality Therapy | 2 | 2009 | 8552 | 0.010 |
Why?
|
Guideline Adherence | 1 | 2012 | 2283 | 0.010 |
Why?
|
Blood Proteins | 1 | 1986 | 1173 | 0.010 |
Why?
|
Educational Status | 1 | 2009 | 2515 | 0.010 |
Why?
|
Inflammation | 1 | 2000 | 10756 | 0.010 |
Why?
|
Treatment Refusal | 1 | 2004 | 430 | 0.010 |
Why?
|
Evidence-Based Medicine | 1 | 2012 | 3696 | 0.010 |
Why?
|
Phosphorus | 2 | 1995 | 333 | 0.010 |
Why?
|
Kaplan-Meier Estimate | 1 | 2010 | 6544 | 0.010 |
Why?
|
Incidence | 1 | 2018 | 21392 | 0.010 |
Why?
|
Models, Biological | 1 | 2015 | 9467 | 0.010 |
Why?
|
Cost of Illness | 1 | 2009 | 1940 | 0.010 |
Why?
|
Iodine Radioisotopes | 2 | 1994 | 1032 | 0.010 |
Why?
|
Pregnancy Complications, Cardiovascular | 1 | 1983 | 516 | 0.010 |
Why?
|
Gastric Juice | 1 | 1978 | 59 | 0.010 |
Why?
|
Animals | 2 | 2020 | 167963 | 0.010 |
Why?
|
Cell Differentiation | 1 | 2015 | 11481 | 0.010 |
Why?
|
T-Lymphocytes | 1 | 1995 | 10181 | 0.010 |
Why?
|
Patient Selection | 1 | 2010 | 4283 | 0.010 |
Why?
|
Melanins | 2 | 1991 | 291 | 0.010 |
Why?
|
Spectrometry, Fluorescence | 2 | 1991 | 687 | 0.010 |
Why?
|
Syndrome | 1 | 1984 | 3280 | 0.010 |
Why?
|
Food, Fortified | 1 | 1998 | 189 | 0.010 |
Why?
|
Patient Readmission | 1 | 1992 | 3323 | 0.010 |
Why?
|
Enflurane | 1 | 1976 | 16 | 0.010 |
Why?
|
Alkalosis | 1 | 1977 | 54 | 0.010 |
Why?
|
Health Facility Planning | 1 | 1976 | 19 | 0.010 |
Why?
|
Health Facility Size | 1 | 1976 | 62 | 0.010 |
Why?
|
Acidosis, Respiratory | 1 | 1976 | 38 | 0.010 |
Why?
|
Ulcer | 1 | 1997 | 204 | 0.010 |
Why?
|
Transplantation, Homologous | 3 | 1980 | 4810 | 0.010 |
Why?
|
Muromonab-CD3 | 1 | 1995 | 104 | 0.010 |
Why?
|
Urea | 2 | 1990 | 446 | 0.010 |
Why?
|
Nutrition Assessment | 1 | 1998 | 727 | 0.010 |
Why?
|
Hospital Bed Capacity | 1 | 1976 | 210 | 0.010 |
Why?
|
Methyl Ethers | 1 | 1976 | 196 | 0.010 |
Why?
|
Gastric Mucosa | 1 | 1978 | 599 | 0.010 |
Why?
|
Diet | 2 | 1989 | 8010 | 0.010 |
Why?
|
Arthritis, Reactive | 1 | 1973 | 20 | 0.010 |
Why?
|
Kidney Tubules | 1 | 1976 | 449 | 0.010 |
Why?
|
Chlamydia | 1 | 1973 | 33 | 0.010 |
Why?
|
Mice | 1 | 2020 | 81208 | 0.010 |
Why?
|
Cyclosporine | 1 | 1995 | 777 | 0.010 |
Why?
|
Proteinuria | 1 | 1995 | 594 | 0.010 |
Why?
|
Regional Blood Flow | 1 | 1976 | 1490 | 0.010 |
Why?
|
Diuretics | 1 | 1995 | 613 | 0.010 |
Why?
|
Calcium Channel Blockers | 1 | 1995 | 694 | 0.010 |
Why?
|
Positive-Pressure Respiration | 1 | 1976 | 636 | 0.010 |
Why?
|
Probability | 2 | 1976 | 2475 | 0.010 |
Why?
|
Ytterbium | 1 | 1990 | 1 | 0.010 |
Why?
|
Inulin | 1 | 1990 | 68 | 0.010 |
Why?
|
Technetium Tc 99m Pentetate | 1 | 1990 | 67 | 0.010 |
Why?
|
Recurrence | 2 | 1980 | 8482 | 0.010 |
Why?
|
Organotechnetium Compounds | 1 | 1990 | 129 | 0.010 |
Why?
|
Pentetic Acid | 1 | 1990 | 209 | 0.010 |
Why?
|
Hemodynamics | 2 | 1983 | 4174 | 0.010 |
Why?
|
Metabolic Clearance Rate | 1 | 1990 | 361 | 0.010 |
Why?
|
Oxygen Consumption | 1 | 1976 | 1843 | 0.010 |
Why?
|
National Health Programs | 1 | 1973 | 441 | 0.010 |
Why?
|
Administration, Oral | 1 | 1997 | 4035 | 0.010 |
Why?
|
Molecular Weight | 1 | 1991 | 2186 | 0.010 |
Why?
|
Leucine | 1 | 1990 | 547 | 0.000 |
Why?
|
Biological Transport, Active | 1 | 1989 | 327 | 0.000 |
Why?
|
Diabetic Nephropathies | 1 | 1995 | 988 | 0.000 |
Why?
|
Fludrocortisone | 1 | 1968 | 24 | 0.000 |
Why?
|
Statistics as Topic | 1 | 1994 | 2362 | 0.000 |
Why?
|
Chromatography, Thin Layer | 1 | 1987 | 212 | 0.000 |
Why?
|
Feasibility Studies | 1 | 1998 | 5201 | 0.000 |
Why?
|
Cardenolides | 1 | 1986 | 17 | 0.000 |
Why?
|
Body Weight | 2 | 1989 | 4611 | 0.000 |
Why?
|
Aspartate Aminotransferases | 1 | 1988 | 416 | 0.000 |
Why?
|
Sensitivity and Specificity | 1 | 2001 | 14660 | 0.000 |
Why?
|
Hyperkalemia | 1 | 1968 | 231 | 0.000 |
Why?
|
Angiography | 1 | 1991 | 1605 | 0.000 |
Why?
|
Alanine Transaminase | 1 | 1988 | 606 | 0.000 |
Why?
|
Fluorescence | 1 | 1987 | 751 | 0.000 |
Why?
|
Acute Disease | 1 | 1976 | 7269 | 0.000 |
Why?
|
Blood Urea Nitrogen | 1 | 1985 | 187 | 0.000 |
Why?
|
Recombinant Proteins | 1 | 1994 | 6538 | 0.000 |
Why?
|
Patient Compliance | 1 | 1995 | 2688 | 0.000 |
Why?
|
Angiotensin II | 1 | 1968 | 849 | 0.000 |
Why?
|
Adaptation, Physiological | 1 | 1990 | 1296 | 0.000 |
Why?
|
Kinetics | 1 | 1990 | 6377 | 0.000 |
Why?
|
Myocardial Infarction | 1 | 1983 | 11891 | 0.000 |
Why?
|
Obstetric Labor Complications | 1 | 1983 | 236 | 0.000 |
Why?
|
Sunlight | 1 | 1982 | 337 | 0.000 |
Why?
|
Gastrins | 1 | 1978 | 74 | 0.000 |
Why?
|
Pepsin A | 1 | 1978 | 66 | 0.000 |
Why?
|
Postoperative Complications | 2 | 1977 | 15697 | 0.000 |
Why?
|
Biotransformation | 1 | 1976 | 166 | 0.000 |
Why?
|
Peptic Ulcer | 1 | 1978 | 219 | 0.000 |
Why?
|
Hyperparathyroidism, Secondary | 1 | 1977 | 125 | 0.000 |
Why?
|
Radioisotope Renography | 1 | 1976 | 61 | 0.000 |
Why?
|
Permeability | 1 | 1978 | 719 | 0.000 |
Why?
|
Fluorides | 1 | 1976 | 134 | 0.000 |
Why?
|
Seasons | 1 | 1982 | 1522 | 0.000 |
Why?
|
Pregnancy | 2 | 1983 | 29749 | 0.000 |
Why?
|
Remission, Spontaneous | 1 | 1976 | 384 | 0.000 |
Why?
|
Suction | 1 | 1977 | 263 | 0.000 |
Why?
|
Insulin | 1 | 1990 | 6597 | 0.000 |
Why?
|
Urography | 1 | 1976 | 312 | 0.000 |
Why?
|
Lithium | 1 | 1978 | 596 | 0.000 |
Why?
|
Phototherapy | 1 | 1977 | 368 | 0.000 |
Why?
|
Sulfacetamide | 1 | 1973 | 3 | 0.000 |
Why?
|
Halitosis | 1 | 1973 | 13 | 0.000 |
Why?
|
Child | 1 | 2001 | 79806 | 0.000 |
Why?
|
Polyethylene Glycols | 1 | 1978 | 1189 | 0.000 |
Why?
|
Ophthalmic Solutions | 1 | 1973 | 304 | 0.000 |
Why?
|
Conjunctivitis | 1 | 1973 | 155 | 0.000 |
Why?
|
Heart Failure | 1 | 1976 | 11847 | 0.000 |
Why?
|
Electrocardiography | 1 | 1983 | 6414 | 0.000 |
Why?
|
Chlamydia Infections | 1 | 1973 | 362 | 0.000 |
Why?
|
Anesthesia, General | 1 | 1976 | 1166 | 0.000 |
Why?
|
Models, Theoretical | 1 | 1976 | 3562 | 0.000 |
Why?
|